Aprogen subsidiary Aprogen Biologics lends KRW 29.1 billion to Ainsfac

Bitget2026/09/23 07:34

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aprogen Biologics set a cash loan of KRW 29.1 billion to Ainsfac, starting Sept. 28, 2026.
Loan carries 4.6% interest. Matures Sept. 27, 2027. Amount equals 10.5% of equity.
Funds earmarked for strategic cash deployment to improve financial structure.
Board decision dated Sept. 23, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprogen Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260923800573), on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Aprogen subsidiary Aprogen Biologics lends KRW 29.1 billion to Ainsfac

You may also like

Crypto prices